Literatura académica sobre el tema "Ligase I Inhibitors"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Ligase I Inhibitors".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Ligase I Inhibitors"
Alomari, Arqam, Robert Gowland, Callum Southwood, Jak Barrow, Zoe Bentley, Jashel Calvin-Nelson, Alice Kaminski et al. "Identification of Novel Inhibitors of Escherichia coli DNA Ligase (LigA)". Molecules 26, n.º 9 (25 de abril de 2021): 2508. http://dx.doi.org/10.3390/molecules26092508.
Texto completoCiarrocchi, Giovanni, Donald G. MacPhee, Les W. Deady y Leann Tilley. "Specific Inhibition of the Eubacterial DNA Ligase by Arylamino Compounds". Antimicrobial Agents and Chemotherapy 43, n.º 11 (1 de noviembre de 1999): 2766–72. http://dx.doi.org/10.1128/aac.43.11.2766.
Texto completoLama, Rati, Samuel L. Galster, Chao Xu, Luke W. Davison, Sherry R. Chemler y Xinjiang Wang. "Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells". Molecules 27, n.º 22 (8 de noviembre de 2022): 7665. http://dx.doi.org/10.3390/molecules27227665.
Texto completoShapiro, Adam B., Ann E. Eakin, Grant K. Walkup y Olga Rivin. "A High-Throughput Fluorescence Resonance Energy Transfer-Based Assay for DNA Ligase". Journal of Biomolecular Screening 16, n.º 5 (11 de marzo de 2011): 486–93. http://dx.doi.org/10.1177/1087057111398295.
Texto completoGorelik, Maryna, Stephen Orlicky, Maria A. Sartori, Xiaojing Tang, Edyta Marcon, Igor Kurinov, Jack F. Greenblatt et al. "Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1–F-box interface". Proceedings of the National Academy of Sciences 113, n.º 13 (14 de marzo de 2016): 3527–32. http://dx.doi.org/10.1073/pnas.1519389113.
Texto completoMarblestone, Jeffrey G., K. G. Suresh Kumar, Michael J. Eddins, Craig A. Leach, David E. Sterner, Michael R. Mattern y Benjamin Nicholson. "Novel Approach for Characterizing Ubiquitin E3 Ligase Function". Journal of Biomolecular Screening 15, n.º 10 (23 de septiembre de 2010): 1220–28. http://dx.doi.org/10.1177/1087057110380456.
Texto completoTobin, Lisa A., Aaron P. Rapoport, Ivana Gojo, Maria R. Baer, Alan E. Tomkinson y Feyruz V. Rassool. "DNA Ligase III Alpha and (Poly-ADP) Ribose Polymerase (PARP1) Are Therapeutic Targets in Imatinib-Resistant (IR) Chronic Myeloid Leukemia (CML)." Blood 114, n.º 22 (20 de noviembre de 2009): 853. http://dx.doi.org/10.1182/blood.v114.22.853.853.
Texto completoTAN, Ghee T., Sangkook LEE, Ik-Soo LEE, Jingwen CHEN, Pete LEITNER, Jeffrey M. BESTERMAN, Douglas A. KINGHORN y John M. PEZZUTO. "Natural-product inhibitors of human DNA ligase I". Biochemical Journal 314, n.º 3 (15 de marzo de 1996): 993–1000. http://dx.doi.org/10.1042/bj3140993.
Texto completoGoldenberg, Seth J., Jeffrey G. Marblestone, Michael R. Mattern y Benjamin Nicholson. "Strategies for the identification of ubiquitin ligase inhibitors". Biochemical Society Transactions 38, n.º 1 (19 de enero de 2010): 132–36. http://dx.doi.org/10.1042/bst0380132.
Texto completoMills, Scott D., Ann E. Eakin, Ed T. Buurman, Joseph V. Newman, Ning Gao, Hoan Huynh, Kenneth D. Johnson et al. "Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial EfficacyIn Vivo". Antimicrobial Agents and Chemotherapy 55, n.º 3 (28 de diciembre de 2010): 1088–96. http://dx.doi.org/10.1128/aac.01181-10.
Texto completoTesis sobre el tema "Ligase I Inhibitors"
Dickens, Michael. "Small molecule inhibitors of Mdm2 E3 ubiquitin ligase activity". Thesis, University of Nottingham, 2011. http://eprints.nottingham.ac.uk/11960/.
Texto completoCressina, Elena. "Inhibitors for the tRNA dependent ligase MurM from streptococcus pneumoniae". Thesis, University of Warwick, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.491471.
Texto completoBesong, Gilbert Ebai. "Design and synthesis of D-Ala-D-Ala ligase inhibitors as novel antibacterials". Thesis, University of Leeds, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414211.
Texto completoLiu, Ran. "Design, Synthesis and Testing of Novel Small Molecule Inhibitors of S-phase Kinase-Associated Protein 2". Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/20999.
Texto completoBrusa, Irene <1991>. "Design and synthesis of E3 ligase RNF5 inhibitors as innovative strategy to trigger mutant CFTR rescue in Cystic Fibrosis". Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2022. http://amsdottorato.unibo.it/10241/1/Brusa_Irene_tesi.pdf.
Texto completoShouksmith, Andrew Eric. "Design and synthesis of small-molecule inhibitors targeting the SCFskp2 E3 ligase and the MDMX-p53 interaction for cancer therapy". Thesis, University of Newcastle upon Tyne, 2014. http://hdl.handle.net/10443/2904.
Texto completoSABBIONI, SIMONE. "CHARACTERIZATION OF THE MOLECULAR MECHANISM RESPONSIBLE FOR THE LOSS OF THE TUMOR SUPPRESSOR NUMB IN BREAST CANCER". Doctoral thesis, Università degli Studi di Milano, 2019. http://hdl.handle.net/2434/609517.
Texto completoGutierrez, Jemy A. "Inhibition and functional characterization of asparagine synthetase". [Gainesville, Fla.] : University of Florida, 2006. http://purl.fcla.edu/fcla/etd/UFE0015619.
Texto completoKaur, Loveleen. "Developing as assay to screen inhibitors for various ATP-dependent ligases". Thesis, University of Westminster, 2009. https://westminsterresearch.westminster.ac.uk/item/90xxw/developing-as-assay-to-screen-inhibitors-for-various-atp-dependent-ligases.
Texto completoChobotova, Katya. "Ligand binding determinants of LIF receptor". Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.244596.
Texto completoLibros sobre el tema "Ligase I Inhibitors"
Helmsen, Sabine. Protein-Ligand-, Protein-Inhibitor- und Protein-Protein-Wechselwirkungen. Wiesbaden: Springer Fachmedien Wiesbaden, 2020. http://dx.doi.org/10.1007/978-3-658-30151-4.
Texto completoHyŏmnyŏktan, Koryŏ Taehakkyo Sanhak. E3, ubiquitin ligase chŏhaeje rŭl wihan E1-E2-E3-substrate cognate pair network chŏngnip kisul kaebal kwa i rŭl iyong han tanangsŏng sinjŭnghugun (ADPKD) ch'iryoje kaebal yŏn'gu =: Study on E1-E2-E3-substrate cognate pair network for E3 ligase inhibitor and application. [Seoul]: Pogŏn Pokchi kajokpu, 2008.
Buscar texto completoJ, Beuth y Pulverer Gerhard, eds. Lectin blocking: New strategies for the prevention and therapy of tumor metastasis and infectious diseases : proceedings of the Intern. Symposium Otzenhausen, May 8-9, 1993. Stuttgart ; New York: Fischer, 1994.
Buscar texto completoStefanis, Leonidas y J. N. Keller. Proteasome in Neurodegeneration. Springer London, Limited, 2007.
Buscar texto completo(Editor), Leonidas Stefanis y J. N. Keller (Editor), eds. The Proteasome in Neurodegeneration. Springer, 2006.
Buscar texto completoRashwan, Hesham. Studies on inhibition of GMP synthetase and MTA phosphorylase. 1986.
Buscar texto completoHelmsen, Sabine. Protein-Ligand-, Protein-Inhibitor- und Protein-Protein-Wechselwirkungen: Einsatz analytischer Methoden zu deren Bestimmung. Springer Spektrum, 2020.
Buscar texto completoCapítulos de libros sobre el tema "Ligase I Inhibitors"
Mattern, Michael R., Michael J. Eddins, Saket Agarwal, David E. Sterner, Matthew P. Kodrasov, K. G. Suresh Kumar, Jian Wu y Benjamin Nicholson. "Proteasome Inhibitors Versus E3 Ligase Inhibitors for Cancer Therapy". En Resistance to Targeted Anti-Cancer Therapeutics, 291–316. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06752-0_12.
Texto completoFu, Xiaoli, Jie Chu, Yuyin Li, Shasha Wang, Jie Zhou, Yujie Dai y Aipo Diao. "Design, Synthesis, and Biological Evaluation of Nedd4 E3 Ubiquitin Ligase Small Molecule Inhibitors". En Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012), 1821–28. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-37925-3_195.
Texto completoMartin, David P., David T. Puerta y Seth M. Cohen. "Metalloprotein Inhibitors". En Ligand Design in Medicinal Inorganic Chemistry, 375–403. Chichester, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118697191.ch14.
Texto completoSayers, Thomas J. "TNF-Related Apoptosis-Inducing Ligand (TRAIL)". En Proteasome Inhibitors in Cancer Therapy, 181–91. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-794-9_15.
Texto completoKos, J., V. Arbanas, V. Turk y A. V. Maksimenko. "Chicken egg white cystatin as a ligand for affinity chromatography". En Cysteine Proteinases and their Inhibitors, editado por Vito Turk, 569–76. Berlin, Boston: De Gruyter, 1986. http://dx.doi.org/10.1515/9783110846836-053.
Texto completoLiang, Shuguang, Wei Xu, Kurumi Y. Horiuchi, Yuan Wang y Haiching Ma. "Chemical Microarrays: A New Tool for Discovery Enzyme Inhibitors". En Ligand-Macromolecular Interactions in Drug Discovery, 149–60. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-244-5_9.
Texto completoWatanabe, Nobumoto y Hiroyuki Osada. "CHAPTER 5. Small Molecule Inhibitors of E3 Ubiquitin Ligases". En Protein–Protein Interaction Regulators, 109–23. Cambridge: Royal Society of Chemistry, 2020. http://dx.doi.org/10.1039/9781788016544-00109.
Texto completoHelmsen, Sabine. "Einleitung und Zielsetzung". En Protein-Ligand-, Protein-Inhibitor- und Protein-Protein-Wechselwirkungen, 1–2. Wiesbaden: Springer Fachmedien Wiesbaden, 2020. http://dx.doi.org/10.1007/978-3-658-30151-4_1.
Texto completoHelmsen, Sabine. "Theoretischer Hintergrund". En Protein-Ligand-, Protein-Inhibitor- und Protein-Protein-Wechselwirkungen, 3–22. Wiesbaden: Springer Fachmedien Wiesbaden, 2020. http://dx.doi.org/10.1007/978-3-658-30151-4_2.
Texto completoHelmsen, Sabine. "Praktische Arbeiten". En Protein-Ligand-, Protein-Inhibitor- und Protein-Protein-Wechselwirkungen, 23–32. Wiesbaden: Springer Fachmedien Wiesbaden, 2020. http://dx.doi.org/10.1007/978-3-658-30151-4_3.
Texto completoActas de conferencias sobre el tema "Ligase I Inhibitors"
Scotti, Francesca, Sanjib Bhakta y John P. Malkinson. "Lasso Peptides and Murein Peptide Ligase Inhibitors as Novel Anti-Mycobacterial Agents". En The 24th American Peptide Symposium. Prompt Scientific Publishing, 2015. http://dx.doi.org/10.17952/24aps.2015.193.
Texto completoShukla, Shirish, Qingjie Zhao, Weijang Ying, Felicia Gray, Kelly Vandenberg, George Lund, Bohdan Boytsov, Shihan He, Jolanta Grembecka y Tomasz Cierpicki. "Abstract 3520: Small molecule inhibitors of ring1B-Bmi1 E3 ligase target polycomb repressive complex 1 activity and regulate cell proliferation". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3520.
Texto completoTseng, Hui-Min, David Shum, Hakim Djaballah y David Scheinberg. "Abstract 3689: Identification of DNA ligase IV inhibitors as possible drug and probe candidates for enhancement of radiation treatment and chemotherapy". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3689.
Texto completoLi, Hua, Elizabeth Umeda, Yingjie Song, Denise Young, Lakshmi Ravindranath, Ahmed Mohamed, Shashwat Sharad et al. "Abstract 4679: Silencing of PMEPA1, a NEDD4 E3 ubiquitin ligase binding protein, stabilizes androgen receptor and confers resistance to AR inhibitors". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4679.
Texto completoDaubriac, Julien, Jonathan Melamed, Unnati Pandya, Harvey I. Pass y Leslie I. Gold. "Abstract LB-068: Inhibitors of Skp2 E3 ligase-mediated degradation of p27kip1 as a novel therapeutic approach to malignant pleural mesothelioma". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-lb-068.
Texto completoEgbuta, Chinaza, Julien Dubrulle, Ana Tellechea, Miguel A. Manzanares, Yunfeng Li, Shanshan Duan, John K. Dickson et al. "Abstract 5231: Small-molecule inhibitors of SCF-Skp2-Cks1 ubiquitin E3 ligase stabilize nuclear p27kip1as a novel therapeutic approach to endometrial cancer". En Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5231.
Texto completoSosin, Angela M., Angelika M. Burger, Dajun Yang, Ramzi M. Mohammad y Ayad Al-Katib. "Abstract 4516: A new class of MDM2 inhibitors cause growth inhibition and stabilize wt p53 in lymphoma cells but do not interfere with MDM2 E3 ligase activity". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-4516.
Texto completoKheraldine, Hadeel, Ishita Gupta, Farhan Cyprian, Semir Vranic y Ala-Eddin Al Moustafa. "The Combination of Dasatinib and PD L1 inhibitor prevents the progression of epithelial mesenchymal transition and dramatically blocks cell invasion of HER2 positive breast cancer cells". En Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0105.
Texto completoMitsuuchi, Yasuhiro, Christopher A. Benetatos, Thomas Haimowitz, Yijun Deng, Angeline C. Mufalli, Martin E. Seipel, Jennifer M. Burns, Gurpreet S. Kapoor, C. Glenn Begley y Stephen M. Condon. "Abstract 1806: Birinapant, a bivalent SMAC-mimetic, promotes efficient cellular IAP E3 ligase activity and formation of a pro-apoptotic RIPK1:caspase-8 complex while monovalent IAP inhibitors are less efficient - implications for therapeutic utility". En Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1806.
Texto completoDuckworth, Benjamin P., Helena I. Boshoff, Clifton E. Barry y Courtney C. Aldrich. "Design of a nucleoside inhibitor of biotin protein ligase from Mycobacterium tuberculosis". En XVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201112199.
Texto completoInformes sobre el tema "Ligase I Inhibitors"
Guo, Lijuan, Xiaoyi Lin, Xin Lin, Yulei Wang, Jiali Lin, Yi Zhang, Xiangqing Chen, Miao Chen, Guochun Zhang y Yifang Zhang. Risk of Interstitial Lung Disease With Use of Programmed Cell Death 1 Inhibitors versus Programmed Cell Death Ligand 1 Inhibitors In Breast Cancer: A meta-analysis and Cases description. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junio de 2023. http://dx.doi.org/10.37766/inplasy2023.6.0007.
Texto completoMatsuyama, Shigemi. Apoptosis Induction by Targeting Interferon Gamma Receptor 2 (IFNgammaR2) in Prostate Cancer: Ligand (IFNgamma)-Independent Novel Function of IFNgammaR2 as a Bax Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2014. http://dx.doi.org/10.21236/ada611816.
Texto completoMatsuyama, Shigemi. Apoptosis Induction by Targeting Interferon Gamma Receptor 2 (IFNgammaR2) in Prostate Cancer: Ligand (IFNgamma)-Independent Novel Function of IFNgammaR2 as a Bax Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2013. http://dx.doi.org/10.21236/ada591011.
Texto completoMatsuyama, Shigemi. Apoptosis Induction by Targeting Interferon Gamma Receptor 2 (IFNgammaR2) in Prostate Cancer: Ligand (IFNgamma)-Independent Novel Function of IFNgammaR2 as a Bax Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2015. http://dx.doi.org/10.21236/ada623598.
Texto completoLiu, Shu, Xin Zhang, Wenhan Yang y Shun Xu. Association of Patient Sex with Efficacy of Programmed Death-1/Ligand-1 Inhibitors in Advanced Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, enero de 2021. http://dx.doi.org/10.37766/inplasy2021.1.0005.
Texto completoAltstein, Miriam y Ronald J. Nachman. Rational Design of Insect Control Agent Prototypes Based on Pyrokinin/PBAN Neuropeptide Antagonists. United States Department of Agriculture, agosto de 2013. http://dx.doi.org/10.32747/2013.7593398.bard.
Texto completoAltstein, Miriam y Ronald Nachman. Rationally designed insect neuropeptide agonists and antagonists: application for the characterization of the pyrokinin/Pban mechanisms of action in insects. United States Department of Agriculture, octubre de 2006. http://dx.doi.org/10.32747/2006.7587235.bard.
Texto completo